TABLE OF CONTENTS
Volume 39, Issue 7 (April (1) 2007)
Review
Challenges and pitfalls in prenatal screening in pregnancies involving allogeneic stem cell transplantation recipients FREE
W Y Au and W C Leung
Bone Marrow Transplant 39: 379-382; advance online publication, February 19, 2007; doi:10.1038/sj.bmt.1705604
Original Articles
Conditioning Regimens
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases FREE
O Ringdén, M Remberger, P Svenberg, B-M Svahn, G Dahllöf, B Gustafsson, Z Hassan, B Omazic, M Uzunel, J Aschan, L Barkholt, J Winiarski, P Ljungman and J Mattsson
Bone Marrow Transplant 39: 383-388; advance online publication, February 19, 2007; doi:10.1038/sj.bmt.1705602
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma FREE
M Schmidt-Hieber, I W Blau, R Trenschel, R Andreesen, G Stuhler, H Einsele, L Kanz, U Keilholz, O Marinets, D W Beelen, A A Fauser, L Volin, T Ruutu, L Uharek, T Fietz, W Knauf, W Hopfenmüller, E Thiel, M Freund and J Casper
Bone Marrow Transplant 39: 389-396; advance online publication, February 19, 2007; doi:10.1038/sj.bmt.1705605
Home administration of high-dose oral busulfan in patients undergoing hematopoietic stem cell transplantation FREE
R H Matthews, M Emami, D G Connaghan, H K Holland and L E Morris
Bone Marrow Transplant 39: 397-400; advance online publication, February 26, 2007; doi:10.1038/sj.bmt.1705610
Stem Cell Mobilisation and Usage
Mobilized peripheral blood stem cells provide rapid reconstitution but impaired long-term engraftment in a mouse model FREE
J S G Yeoh, A Ausema, P Wierenga, G de Haan and R van Os
Bone Marrow Transplant 39: 401-409; advance online publication, February 12, 2007; doi:10.1038/sj.bmt.1705601
Pediatric Transplants
Hematopoietic cell transplantation for Chediak–Higashi syndrome FREE
M Eapen, C A DeLaat, K S Baker, M S Cairo, M J Cowan, J Kurtzberg, C G Steward, P A Veys and A H Filipovich
Bone Marrow Transplant 39: 411-415; advance online publication, February 12, 2007; doi:10.1038/sj.bmt.1705600
Allografting
Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors FREE
R M Sobecks, E J Ball, J P Maciejewski, L A Rybicki, S Brown, M Kalaycio, B Pohlman, S Andresen, K S Theil, R Dean and B J Bolwell
Bone Marrow Transplant 39: 417-424; advance online publication, February 19, 2007; doi:10.1038/sj.bmt.1705609
Post-Transplant Events
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy FREE
S M Trifilio, C L Bennett, P R Yarnold, J M McKoy, J Parada, J Mehta, G Chamilos, F Palella, L Kennedy, K Mullane, M S Tallman, A Evens, M H Scheetz, W Blum and D P Kontoyiannis
Bone Marrow Transplant 39: 425-429; advance online publication, February 19, 2007; doi:10.1038/sj.bmt.1705614
Graft-versus-Host Disease
Effect of pilocarpine hydrochloride on unstimulated whole saliva flow rate and composition in patients with chronic graft-versus-host disease (cGVHD) FREE
F Agha-Hosseini, I Mirzaii-Dizgah, L Ghavamzadeh, A Ghavamzadeh and Z Tohidast-Acrad
Bone Marrow Transplant 39: 431-434; advance online publication, February 19, 2007; doi:10.1038/sj.bmt.1705621
Letter to the Editor
Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease? FREE
Y Loh, Y Oyama, L Statkute, L Verda, K Quigley, K Yaung, W Barr, B Jovanovic and R K Burt
Bone Marrow Transplant 39: 435-437; advance online publication, February 19, 2007; doi:10.1038/sj.bmt.1705611
